Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users.

Huik K, Avi R, Pauskar M, Kallas E, Jõgeda EL, Karki T, Marsh K, Des Jarlais D, Uusküla A, Lutsar I.

Infect Genet Evol. 2013 Dec;20:78-82. doi: 10.1016/j.meegid.2013.08.008. Epub 2013 Aug 17.

2.

Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users.

Kallas E, Huik K, Pauskar M, Jõgeda EL, Karki T, Des Jarlais D, Uusküla A, Avi R, Lutsar I.

Infect Genet Evol. 2015 Mar;30:175-80. doi: 10.1016/j.meegid.2014.12.023. Epub 2014 Dec 24.

PMID:
25542814
3.

CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users.

Huik K, Avi R, Carrillo A, Harper N, Pauskar M, Sadam M, Karki T, Krispin T, Kongo UK, Jermilova T, Rüütel K, Talu A, Abel-Ollo K, Uusküla A, Ahuja SK, He W, Lutsar I.

PLoS One. 2013 Jul 25;8(7):e70561. doi: 10.1371/journal.pone.0070561. Print 2013.

4.

CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Huik K, Sadam M, Karki T, Avi R, Krispin T, Paap P, Rüütel K, Uusküla A, Talu A, Abel-Ollo K, Lutsar I.

J Infect Dis. 2010 Mar;201(5):730-9. doi: 10.1086/650491.

5.

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.

Huik K, Avi R, Pauskar M, Kallas E, Jõgeda EL, Karki T, Rüütel K, Talu A, Abel-Ollo K, Uusküla A, Carrillo A, Ahuja SK, He W, Lutsar I.

PLoS One. 2016 Jun 15;11(6):e0156850. doi: 10.1371/journal.pone.0156850. eCollection 2016.

6.

A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.

Sironi M, Biasin M, Cagliani R, Forni D, De Luca M, Saulle I, Lo Caputo S, Mazzotta F, Macías J, Pineda JA, Caruz A, Clerici M.

J Immunol. 2012 Jan 15;188(2):818-23. doi: 10.4049/jimmunol.1102179. Epub 2011 Dec 14.

7.

Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population.

Barkhash AV, Voevoda MI, Romaschenko AG.

Antiviral Res. 2013 Aug;99(2):136-8. doi: 10.1016/j.antiviral.2013.05.008. Epub 2013 May 27.

PMID:
23721942
8.

A SDF1 genetic variant confers resistance to HIV-1 infection in intravenous drug users in China.

Gong X, Liu Y, Liu FL, Jin L, Wang H, Zheng YT.

Infect Genet Evol. 2015 Aug;34:137-42. doi: 10.1016/j.meegid.2015.07.012. Epub 2015 Jul 10.

PMID:
26168882
9.

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.

Jiménez-Sousa MA, Rallón N, Berenguer J, Pineda-Tenor D, López JC, Soriano V, Guzmán-Fulgencio M, Cosín J, Retana D, García-Álvarez M, Miralles P, Benito JM, Resino S.

J Clin Virol. 2015 Apr;65:62-7. doi: 10.1016/j.jcv.2015.02.004. Epub 2015 Feb 9.

PMID:
25766991
10.

Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.

Studzińska M, Jabłońska A, Wiśniewska-Ligier M, Nowakowska D, Gaj Z, Leśnikowski ZJ, Woźniakowska-Gęsicka T, Wilczyński J, Paradowska E.

PLoS One. 2017 Jan 3;12(1):e0169420. doi: 10.1371/journal.pone.0169420. eCollection 2017.

11.

Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.

Zwolińska K, Knysz B, Rybka K, Pazgan-Simon M, Gąsiorowski J, Sobczyński M, Gładysz A, Piasecki E.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):54-60. doi: 10.1089/AID.2011.0362. Epub 2012 Oct 9.

PMID:
22957692
12.

A toll-like receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis.

Ikezoe K, Handa T, Tanizawa K, Kubo T, Ito I, Sokai A, Nakatsuka Y, Nagai S, Izumi T, Mishima M.

Tissue Antigens. 2015 Mar;85(3):204-8. doi: 10.1111/tan.12535.

PMID:
25720507
13.

[A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].

Bao Y, Zhang Y, Liang Y, Chen M, Sun J, Tan H.

Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Jun;49(6):513-7. Chinese.

PMID:
26310336
14.

Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection.

Svensson A, Tunbäck P, Nordström I, Padyukov L, Eriksson K.

J Gen Virol. 2012 Aug;93(Pt 8):1717-24. doi: 10.1099/vir.0.042572-0. Epub 2012 May 2.

PMID:
22552940
15.

Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study).

Ghosn J, Fouquet B, Quertainmont Y, Salmon D, Sahali S, Rioux C, Duvivier C, Mole M, Delfraissy JF, Misrahi M.

J Med Virol. 2015 Apr;87(4):619-24. doi: 10.1002/jmv.24088. Epub 2015 Jan 21.

PMID:
25611191
16.

Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.

Crum RM, Galai N, Cohn S, Celentano DD, Vlahov D.

Alcohol Clin Exp Res. 1996 Apr;20(2):364-71.

PMID:
8730231
17.

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81.

PMID:
11511825
18.

A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection.

Kindberg E, Vene S, Mickiene A, Lundkvist Å, Lindquist L, Svensson L.

J Infect Dis. 2011 Feb 15;203(4):523-8. doi: 10.1093/infdis/jiq082. Epub 2011 Jan 7.

19.

A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse.

Chen DN, Song CG, Yu KD, Jiang YZ, Ye FG, Shao ZM.

PLoS One. 2015 Jul 30;10(7):e0133184. doi: 10.1371/journal.pone.0133184. eCollection 2015.

20.

The first report of CCR5 delta 32 mutant in Thai injecting drug users.

Ruchusatsawat N, Vongsheree S, Thaisri H, Phutiprawan T.

Asian Pac J Allergy Immunol. 2000 Jun;18(2):93-8.

PMID:
10928621

Supplemental Content

Support Center